Tag Archives: health

Rare Disease Day: Families and Advocacy Groups Drive Treatments for Rare Diseases

Gavin and Bella Today, we celebrate Rare Disease Day to recognize the path to treatments and cures is paved by families and caregivers working with advocacy groups, medical advisors, and dedicated researchers. Of the many people touched by and involved in the world of rare diseases, patients and their families are inarguably the most passionate advocates for rare disease research. When their disease-focused family foundations work together, pool their funds, and align their efforts, the results can be Read More >
Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Renewing the Project BioShield Act: What Has It Bought and Wrought?

Syringe

In the next several months, the U.S. Government will decide whether to continue the funding and authorities associated with Project BioShield, which expanded the U.S. stockpile of medical countermeasures (MCMs) for potential chemical, biological, radiological and nuclear (CBRN) attacks. Congress established Project BioShield in 2004 and provided $5.68B for procurement over 10 years. Two years later, it created the Biomedical Advanced Research and Development Authority (BARDA) to oversee BioShield’s advanced development and procurement efforts. To Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

How the Biotechnology Industry Can Combat Doping in Sports

Track

Biotechnology companies work every day to solve some of our biggest global challenges – fighting disease, hunger and pollution. Yet, we in the biotech industry are strongly aware that our products can also be misused in the wrong hands. The same medicines that can be used to help children with devastating genetic deficiencies and growth disorders, or to help a chemotherapy patient combat cancer, can also be abused by healthy athletes to gain an unfair Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , , , ,

FDASIA: A Step Forward for Patients

fdasia-panel

Earlier this year, Congress passed and President Obama signed the FDA Safety and Innovation Act (FDASIA) which included a re-authorization of the Prescription Drug User Fee Act (PDUFA). PDUFA provides essential funding to the FDA by authorizing the agency to charge user fees to companies seeking to have products reviewed. Originally enacted in 1992, it must be reauthorized every 5 years. Sara Radcliffe, executive vice president of health at BIO, moderated a panel of experts and advocates Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

Delivering on the Promise of Personalized Medicine

185x185_ad_btn_home

As sequencing moves out of the lab and into the clinic, a host of players must get involved to make our collective promises of personalized medicine a reality. CEOs, entrepreneurs, researchers, clinicians, regulators and payers need to work together to take on the next challenges in the implementation of personalized medicine. Some of those challenges include: Cost vs. Benefit: How do we define and benefit from transformational technologies? Form vs. Function: What about the less Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,